Christopher J. Fraser, MD

Queensland Children’s Hospital, Australia

Disclosure(s): No financial relationships to disclose

Poster(s):

• 623 - Preliminary Dosing for Adolescent Hematopoietic Stem-Cell Transplant (HSCT) Recipients Based on Pharmacokinetic (PK), Safety, and Efficacy Data of Letermovir (LET) for Cytomegalovirus (CMV) Prophylaxis
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET